"InMedica – tai pirminės asmens sveikatos priežiūros įstaigų tinklas, teikiantis paslaugas įvairiuose šalies miestuose. Mes ne tik rūpinamės savo pacientais jiems susirgus, bet taip pat ir padedame pasirinkti tinkamas profilaktikos priemones bei ugdyti sveiko gyvenimo įpročius. Esame sudarę sutartis su ligonių kasomis, todėl visos paslaugos kompensuojamos iš PSDF biudžeto, mūsų pacientams teikiamos nemokamai."

During the past decade, JSC "InMedica" conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "JSC "InMedica"" #1 collaborator was "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "JSC "InMedica"" are "Meningitis, Meningococcal" (1 trials) and "Resistant Hypertension" (1 trials). Many other conditions were trialed in "JSC "InMedica"" in a lesser frequency.

Most popular intervention types in "JSC "InMedica"" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aprocitentan 12.5 mg" (1 trials), "Aprocitentan 25 mg" (1 trials), "Placebo" (1 trials), "control" (1 trials) and "rLP2086 vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "JSC "InMedica"" are 2 trials for "All" genders.

Currently, there are NaN active trials in "JSC "InMedica"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in JSC "InMedica", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JSC "InMedica", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".